Endoscopic ultrasound-guided ablation with hybridtherm probe in addition to chemotherapy versus chemotherapy alone for the treatment of locally advanced or borderline resectable pancreatic cancer: a phase II randomized controlled trial / S.G.G. Testoni, M.C. Petrone, M. Reni, G. Rossi, M. Barbera, V. Nicoletti, S. Gusmini, G. Balzano, W. Linzenbold, M. Enderle, E. Della-Torre, F. De Cobelli, C. Doglioni, M. Falconi, G. Capurso, P.G. Arcidiacono. - In: DIGESTIVE AND LIVER DISEASE. - ISSN 1590-8658. - 53:suppl. 3(2021), pp. OC.03.7.S104-OC.03.7.S104. ( 27. National Congress of Digestive Disease, Italian Federation of Societies of Digestive Diseases - FISMAD2021).
Endoscopic ultrasound-guided ablation with hybridtherm probe in addition to chemotherapy versus chemotherapy alone for the treatment of locally advanced or borderline resectable pancreatic cancer: a phase II randomized controlled trial
S.G.G. TestoniPrimo
;
2021
| File | Dimensione | Formato | |
|---|---|---|---|
|
OC-03-7-ENDOSCOPIC-ULTRASOUND-GUIDED-ABLATION-WITH-HYBRIDTHERM-P_2021_Digest.pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Licenza:
Nessuna licenza
Dimensione
62.22 kB
Formato
Adobe PDF
|
62.22 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
